Interferon Epsilon-Mediated Antiviral Activity Against Human Metapneumovirus and Respiratory Syncytial Virus

Iván Martínez-Espinoza1, Pius I Babawale1, Hannah Miletello1

  • 1Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.

Vaccines
|October 26, 2024
PubMed
Abstract

Insights

Interferon epsilon (IFN-ε), a type I interferon, is expressed in lung cells during respiratory virus infections. Treatment with IFN-ε restricts viral replication, highlighting its role in respiratory antiviral immunity.

Area of Science:

  • Immunology
  • Virology
  • Respiratory Medicine

Background:

  • Type I interferons (IFNs) are crucial for host defense against pathogens.
  • Interferon epsilon (IFN-ε) shows antiviral activity in various tissues but its role in respiratory infections is unclear.

Purpose of the Study:

  • To investigate the expression and function of IFN-ε in airway epithelial cells during respiratory viral infections.
  • To determine the relevance of IFN-ε in the context of human metapneumovirus (HMPV) and respiratory syncytial virus (RSV) infections.

Main Methods:

  • Analysis of IFN-ε expression in alveolar and bronchial epithelial cells upon HMPV and RSV infection.
  • Molecular characterization of IFN-ε induction pathways, including the role of RIG-I.
  • Assessment of the antiviral effects of recombinant human IFN-ε (rhIFN-ε) on airway epithelial cells.

Main Results:

  • IFN-ε is expressed in human bronchial and alveolar epithelial cells following HMPV and RSV infection.
  • RIG-I expression is essential for optimal IFN-ε induction by these viruses.
  • rhIFN-ε treatment upregulates IFN-stimulated genes (ISGs) and significantly inhibits HMPV and RSV replication.

Conclusions:

  • IFN-ε plays a significant role in the innate immune response against respiratory viral infections.
  • These findings establish IFN-ε as a key antiviral factor in the respiratory tract.